183 related articles for article (PubMed ID: 35755064)
1. Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.
Rao J; Li S; Wang X; Cheng Q; Ji Y; Fu W; Huang H; Shi L; Wu X
Front Med (Lausanne); 2022; 9():851808. PubMed ID: 35755064
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
3. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
[TBL] [Abstract][Full Text] [Related]
4. FoxP3
Meng H; Zheng S; Zhou Q; Gao Y; Ni Y; Liang H; Chen S
Front Neurol; 2021; 12():755356. PubMed ID: 34975721
[No Abstract] [Full Text] [Related]
5. Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.
Zhang M; Guo J; Li H; Zhou Y; Tian F; Gong L; Wang X; Li Z; Zhang W
J Mol Neurosci; 2013 Jun; 50(2):317-23. PubMed ID: 23397576
[TBL] [Abstract][Full Text] [Related]
6. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
7. Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis.
Mu Y; Huang X; Yang Y; Huang Z; Chen J; Li S; Dong Y; Chen F; Zhang R; Chen J; Feng H; Zhou Q
Gene; 2024 Feb; 896():148034. PubMed ID: 38013129
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis patients have reduced resting and increased activated CD4
Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
[TBL] [Abstract][Full Text] [Related]
9. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
10. CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
Sakuma H; Katayama A; Saito Y; Komaki H; Nakagawa E; Sugai K; Sasaki M
Brain Dev; 2011 May; 33(5):442-4. PubMed ID: 20797828
[TBL] [Abstract][Full Text] [Related]
11. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
12. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
14. Differential Gut Microbiota and Fecal Metabolites Related With the Clinical Subtypes of Myasthenia Gravis.
Tan X; Huang Y; Chai T; Zhao X; Li Y; Wu J; Zhang H; Duan J; Liang W; Yin B; Cheng K; Yu G; Zheng P; Xie P
Front Microbiol; 2020; 11():564579. PubMed ID: 33013794
[TBL] [Abstract][Full Text] [Related]
15. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modifications of blood serum proteins in myasthenia gravis.
Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
[TBL] [Abstract][Full Text] [Related]
17. Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.
Wang JN; Cao XX; Zhao AL; Cai H; Wang X; Li J
Cancer Cell Int; 2018; 18():187. PubMed ID: 30479566
[TBL] [Abstract][Full Text] [Related]
18. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
Guan YZ; Cui LY; Liu MS; Niu JW
Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
20. Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance.
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):619-624. PubMed ID: 28650331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
